Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-Label 12-Month Safety and Efficacy Study of Levodopa-Carbidopa Intestinal Gel in Levodopa-Responsive Parkinson's Disease Subjects
2006-000578-53Phase 3Completed
- Sponsor
- Abbott Laboratories
- Start
- Oct 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of levodopa in Parkinson's disease (PD), sponsored by Abbott Laboratories. Primary endpoint: Safety over 12 months. Started Oct 2008; status: completed.
02
Drugs
levodopa
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on 2006-000578-53.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-000578-53.